MIRATI THERAPEUTICS INC (MRTX)

US60468T1051 - Common Stock

58.7  -0.1 (-0.17%)

After market: 58.99 +0.29 (+0.49%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
13.4M
301.20%		72.09M
437.99%		12.44M
-82.74%		62.951M
406.04%
EBITDA
YoY % growth
-368.72M
-66.20%		-571.4M
-54.97%		-756.66M
-32.42%		-714.041M
5.63%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-369.36M
-66.30%		-573.18M
-55.18%		-759.59M
-32.52%		-536.499M
29.37%
Operating Margin
-2,756.42%-795.09%-6,106.03%-852.25%
EPS
YoY % growth
-7.95
-40.96%		-11.17
-40.50%		-13.18
-17.99%		-11.33
14.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-2.67
23.91%
Revenue
Q2Q % growth		25.741M
2,667.85%
EBITDA
Q2Q % growth		-183.6MN/AN/AN/AN/A
EBIT
Q2Q % growth		-157.111M
25.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -2.49
19.42%		-2.900.4114.01%
Q2 2023
Q2Q % growth		 -3.04
4.40%		-3.230.196.02%
Q1 2023
Q2Q % growth		 -3.18
6.47%		-3.620.4412.21%
Q4 2022
Q2Q % growth		 -3.51
5.65%		-3.620.113.16%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 16.4M
202.03%		18.97M-2.57M-13.55%
Q2 2023
Q2Q % growth		 13.69M
155.41%		13.78M-90K-0.65%
Q1 2023
Q2Q % growth		 7.17M
909.86%		4.874M2.296M47.11%
Q4 2022
Q2Q % growth		 930K
210.00%		2.318M-1.388M-59.88%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.83% 2.99% 0.29% 4.82%
Revenue-0.7% 2.49% -2.26% -3.77%